• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

STAT2 Signaling Regulates Macrophage Phenotype During Influenza and Bacterial Super-Infection

tetano

Editor, Senior Moderator
Front Immunol. 2018 Sep 25;9:2151. doi: 10.3389/fimmu.2018.02151. eCollection 2018.
[h=1]STAT2 Signaling Regulates Macrophage Phenotype During Influenza and Bacterial Super-Infection.[/h] Gopal R[SUP]1[/SUP], Lee B[SUP]2[/SUP], McHugh KJ[SUP]1[/SUP], Rich HE[SUP]1[/SUP], Ramanan K[SUP]1[/SUP], Mandalapu S[SUP]1[/SUP], Clay ME[SUP]1[/SUP], Seger PJ[SUP]1[/SUP], Enelow RI[SUP]3[/SUP], Manni ML[SUP]1[/SUP], Robinson KM[SUP]4[/SUP], Rangel-Moreno J[SUP]5[/SUP], Alcorn JF[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Influenza is a common respiratory virus that infects between 5 and 20% of the US population and results in 30,000 deaths annually. A primary cause of influenza-associated death is secondary bacterial pneumonia. We have previously shown that influenza induces type I interferon (IFN)-mediated inhibition of Type 17 immune responses, resulting in exacerbation of bacterial burden during influenza and Staphylococcus aureus super-infection. In this study, we investigated the role of STAT2 signaling during influenza and influenza-bacterial super-infection in mice. Influenza-infected STAT2 [SUP]-/-[/SUP] mice had increased morbidity, viral burden, and inflammation when compared to wild-type mice. Despite an exaggerated inflammatory response to influenza infection, we found increased bacterial control and survival in STAT2 deficient mice during influenza-MRSA super-infection compared to controls. Further, we found that increased bacterial clearance during influenza-MRSA super-infection is not due to rescue of Type 17 immunity. Absence of STAT2 was associated with increased accumulation of M1, M2 and M1/M2 co-expressing macrophages during influenza-bacterial super-infection. Neutralization of IFNγ (M1) and/or Arginase 1 (M2) impaired bacterial clearance in Stat2 [SUP]-/-[/SUP] mice during super-infection, demonstrating that pulmonary macrophages expressing a mixed M1/M2 phenotype promote bacterial control during influenza-bacterial super-infection. Together, these results suggest that the STAT2 signaling is involved in suppressing macrophage activation and bacterial control during influenza-bacterial super-infection. Further, these studies reveal novel mechanistic insight into the roles of macrophage subpopulations in pulmonary host defense.


[h=4]KEYWORDS:[/h] STAT2; Staphylococcus aureus; influenza; lung; macrophages; pneumonia; super-infection

PMID: 30337919 PMCID: PMC6178135 DOI: 10.3389/fimmu.2018.02151
 
Back
Top Bottom